|
1
|
Luscher TF: Heart failure: The
cardiovascular epidemic of the 21st century. Eur Heart J.
36:395–397. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
The L: Heart failure: The need for
improved treatment and care. Lancet. 392:4512018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Persson H, Linder-Klingsell E, Eriksson SV
and Erhardt L: Heart failure after myocardial infarction: The
importance of diastolic dysfunction. A prospective clinical and
echocardiographic study. Eur Heart J. 16:496–505. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cech TR and Steitz JA: The noncoding RNA
revolution-trashing old rules to forge new ones. Cell. 157:77–94.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
D'Onofrio N, Servillo L and Balestrieri
ML: SIRT1 and SIRT6 signaling pathways in cardiovascular disease
protection. Antioxid Redox Signal. 28:711–732. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alcendor RR, Gao S, Zhai P, Zablocki D,
Holle E, Yu X, Tian B, Wagner T, Vatner SF and Sadoshima J: Sirt1
regulates aging and resistance to oxidative stress in the heart.
Circ Res. 100:1512–1521. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Waldman M, Cohen K, Yadin D, Nudelman V,
Gorfil D, Laniado-Schwartzman M, Kornwoski R, Aravot D, Abraham NG,
Arad M and Hochhauser E: Regulation of diabetic cardiomyopathy by
caloric restriction is mediated by intracellular signaling pathways
involving ‘SIRT1 and PGC-1alpha’. Cardiovasc Diabetol. 17:1112018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang H, Bi Y, Xue L, Wang J, Lu Y, Zhang
Z, Chen X, Chu Y, Yang R, Wang R and Liu G: Multifaceted modulation
of SIRT1 in cancer and inflammation. Crit Rev Oncog. 20:49–64.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong G, Wang B, An Y, Li J, Wang X, Jia J
and Yang Q: SIRT1 suppresses the migration and invasion of gastric
cancer by regulating ARHGAP5 expression. Cell Death Dis. 9:9772018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang C, Sun X, Qiu Z and Chen A:
MiR-138-5p exacerbates hypoxia/reperfusion-induced heart injury
through the inactivation of SIRT1-PGC-1alpha. Inflamm Res.
68:867–876. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang J, Yang XS, Zhang Q, Zhuang X, Dong
XK, Jiang YH, Tao YN and Yang CH: Downregulated LINC01614
ameliorates Hypoxia/reoxygenation-stimulated myocardial injury by
directly sponging microRNA-138-5p. Dose Response.
18:15593258209137862020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Minicucci MF, Azevedo PS, Polegato BF,
Paiva SA and Zornoff LA: Heart failure after myocardial infarction:
Clinical implications and treatment. Clin Cardiol. 34:410–414.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang L, Wang YN, Ju JM, Shabanova A, Li
Y, Fang RN, Sun JB, Guo YY, Jin TZ, Liu YY, et al: Mzb1 protects
against myocardial infarction injury in mice via modulating
mitochondrial function and alleviating inflammation. Acta Pharmacol
Sinica. Aug 5–2020.doi: 10.1038/s41401-020-0489-0 (Epub ahead of
print).
|
|
14
|
Wei Q, Zhou HY, Shi XD, Cao HY and Qin L:
Long noncoding RNA NEAT1 promotes myocardiocyte apoptosis and
suppresses proliferation through regulation of miR-129-5p. J
Cardiovasc Pharmacol. 74:535–541. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Piek A, Suthahar N, Voors AA, de Boer RA
and Sillje HHW: A combined bioinformatics, experimental and
clinical approach to identify novel cardiac specific heart failure
biomarkers: Is Dickkopf-3 (DKK3) a possible candidate? Eur J Heart
Fail. 22:2065–2074. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi X, Verma S, Yun J, Brand-Arzamendi K,
Singh KK, Liu X, Garg A, Quan A and Wen XY: Effect of empagliflozin
on cardiac biomarkers in a zebrafish model of heart failure: Clues
to the EMPA-REG OUTCOME trial? Mol Cell Biochem. 433:97–102. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lelonek M, Stopczynska I, Koroscik E,
Straburzynska-Migaj E and Gruchala M: Multicenter experiences with
levosimendan therapy and its safety in patients with decompensated
advanced heart failure. Adv Clin Exp Med. 29:1305–1312. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mia MM, Cibi DM, Abdul Ghani SAB, Song W,
Tee N, Ghosh S, Mao J, Olson EN and Singh MK: YAP/TAZ deficiency
reprograms macrophage phenotype and improves infarct healing and
cardiac function after myocardial infarction. PLoS Biol.
18:e30009412020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li J, Jia L, Hao Z, Xu Y, Shen J, Ma C, Wu
J, Zhao T, Zhi Y, Li P, et al: Site-specific N-glycoproteomic
analysis reveals upregulated sialylation and core fucosylation
during transient regeneration loss in neonatal mouse hearts. J
Proteome Res. 19:3191–3200. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Badreddin A, Fady Y, Attia H, Hafez M,
Khairallah A, Johar D and Bernstein L: What role does the stress
response have in congestive heart failure? J Cell Physiol.
233:2863–2870. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szobi A, Gonçalvesová E, Varga ZV, Leszek
P, Kuśmierczyk M, Hulman M, Kyselovič J, Ferdinandy P and Adameová
A: Analysis of necroptotic proteins in failing human hearts. J
Transl Med. 15:862017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ravingerová T, Čarnická S, Nemčeková M,
Ledvényiová V, Adameová A, Khandelwal VK, Zálešák M and Kolář F:
The impact of lifestyle-related risk factors on cardiac response to
ischemia and possibilities to restore impaired ischemic tolerance.
Physiol Res. 61 (Suppl 2):S1–S10. 2012. View Article : Google Scholar
|
|
24
|
Turer AT and Hill JA: Pathogenesis of
myocardial ischemia-reperfusion injury and rationale for therapy.
Am J Cardiol. 106:360–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gu M, Wang J, Wang Y, Xu Y, Zhang Y, Wu W
and Liao S: miR-147b inhibits cell viability and promotes apoptosis
of rat H9c2 cardiomyocytes via down-regulating KLF13 expression.
Acta Biochim Biophys Sin (Shanghai). 50:288–297. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Adam O, Lohfelm B, Thum T, Gupta SK, Puhl
SL, Schafers HJ, Böhm M and Laufs U: Role of miR-21 in the
pathogenesis of atrial fibrosis. Basic Res Cardiol. 107:2782012.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Satoh M, Minami Y, Takahashi Y, Tabuchi T
and Nakamura M: Expression of microRNA-208 is associated with
adverse clinical outcomes in human dilated cardiomyopathy. J Card
Fail. 16:404–410. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van Rooij E, Sutherland LB, Liu N,
Williams AH, McAnally J, Gerard RD, Richardson JA and Olson EN: A
signature pattern of stress-responsive microRNAs that can evoke
cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA.
103:18255–18260. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu D, Gu L, Li Z, Jin W, Lu Q and Ren T:
miR-138-5p suppresses lung adenocarcinoma cell
epithelial-mesenchymal transition, proliferation and metastasis by
targeting ZEB2. Pathol Res Pract. 215:861–872. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Zhao Y, Cao W, Wang C, Sun B, Chen
J, Li S, Chen J, Cui M, Zhang B, et al: miR-138-5p acts as a tumor
suppressor by targeting hTERT in human colorectal cancer. Int J
Clin Exp Pathol. 10:11516–11525. 2017.PubMed/NCBI
|
|
31
|
Ma J, Zhang Y, Ji H, Chen L, Chen T, Guo
C, Zhang S, Jia J and Niu P: Overexpression of miR-138-5p
suppresses MnCl2-induced autophagy by targeting SIRT1 in
SH-SY5Y cells. Environ Toxicol. 34:539–547. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Luan B and Sun C: MiR-138-5p affects
insulin resistance to regulate type 2 diabetes progression through
inducing autophagy in HepG2 cells by regulating SIRT1. Nutr Res.
59:90–98. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsu CP, Odewale I, Alcendor RR and
Sadoshima J: Sirt1 protects the heart from aging and stress. Biol
Chem. 389:221–231. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kutsche HS, Schreckenberg R, Weber M,
Hirschhauser C, Rohrbach S, Li L, Niemann B, Schulz R and Schlüter
KD: Alterations in glucose metabolism during the transition to
heart failure: The contribution of UCP-2. Cells. 9:5522020.
View Article : Google Scholar
|
|
35
|
Hariharan N, Maejima Y, Nakae J, Paik J,
Depinho RA and Sadoshima J: Deacetylation of FoxO by Sirt1 plays an
essential role in mediating starvation-induced autophagy in cardiac
myocytes. Circ Res. 107:1470–1482. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gottlieb RA, Finley KD and Mentzer RM Jr:
Cardioprotection requires taking out the trash. Basic Res Cardiol.
104:169–180. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sulaiman M, Matta MJ, Sunderesan NR, Gupta
MP, Periasamy M and Gupta M: Resveratrol, an activator of SIRT1,
upregulates sarcoplasmic calcium ATPase and improves cardiac
function in diabetic cardiomyopathy. Am J Physiol Heart Circ
Physiol. 298:H833–H843. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chen X, Zhang X, Gross S, Houser SR and
Soboloff J: Acetylation of SERCA2a, another target for heart
failure treatment? Circ Res. 124:1285–1287. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dioum EM, Chen R, Alexander MS, Zhang Q,
Hogg RT, Gerard RD and Garcia JA: Regulation of hypoxia-inducible
factor 2alpha signaling by the stress-responsive deacetylase
sirtuin 1. Science. 324:1289–1293. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sano M, Minamino T, Toko H, Miyauchi H,
Orimo M, Qin Y, Akazawa H, Tateno K, Kayama Y, Harada M, et al:
p53-induced inhibition of Hif-1 causes cardiac dysfunction during
pressure overload. Nature. 446:444–448. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen R, Dioum EM, Hogg RT, Gerard RD and
Garcia JA: Hypoxia increases sirtuin 1 expression in a
hypoxia-inducible factor-dependent manner. J Biol Chem.
286:13869–13878. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Hong W, Tatsuo S, Shou-Dong W, Qian Z,
Jian-Feng H, Jue W, Chen J, Hai-Yan Q and Yue-Jin Y: Resveratrol
upregulates cardiac SDF-1 in mice with acute myocardial infarction
through the deacetylation of cardiac p53. PLoS One.
10:e01289782015. View Article : Google Scholar : PubMed/NCBI
|
